Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Cohort Study to Investigate the Safety and Efficacy of Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)

NCT05499026 is registered in ClinicalTrials.gov with Leadiant Biosciences Ltd. as lead sponsor.

NCT NCT05499026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05499026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Cohort Study to Investigate the Safety and Efficacy of Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)
Lead sponsor
Leadiant Biosciences Ltd.
Phase
Observational
Overall status
Completed
Start date
December 9, 2014
Completion date
June 3, 2015
Enrollment
28 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrotendinous xanthomatoses